Clinical Trial Update: A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human Phase 1 (and Phase 2) study of the investigational therapy TST003 is being conducted in adults with solid tumors, including locally advanced an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer
• Solid Tumor

Drugs mentioned

• TST003

Snippet

Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. | Conditions: Locally Advanced Solid Tumor, Metastatic Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING